B Cell Siglecs–News on Signaling and Its Interplay With Ligand Binding
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
CD22 and Siglec-G are members of the Siglec family. Both are inhibitory co-receptors on the surface of B cells and inhibit B-cell receptor induced signaling, characterized by inhibition of the calcium mobilization and cellular activation. CD22 functions predominantly as an inhibitor on conventional B cells, while Siglec-G is an important inhibitor on the B1a-cell subset. These two B-cell Siglecs do not only inhibit initial signaling, but also have an important function in preventing autoimmunity, as double deficient mice develop a lupus-like phenotype with age. Siglecs are characterized by their conserved ability to bind terminal sialic acid of glycans on the cell surface, which is important to regulate the inhibitory role of Siglecs. While CD22 binds α2,6-linked sialic acids, Siglec-G can bind both α2,6-linked and α2,3-linked sialic acids. Interestingly, ligand binding is differentially regulating the ability of CD22 and Siglec-G to control B-cell activation. Within the last years, quite a few studies focused on the different functions of B-cell Siglecs and the interplay of ligand binding and signal inhibition. This review summarizes the role of CD22 and Siglec-G in regulating B-cell receptor signaling, membrane distribution with the importance of ligand binding, preventing autoimmunity and the role of CD22 beyond the naïve B-cell stage. Additionally, this review article features the long time discussed interaction between CD45 and CD22 with highlighting recent data, as well as the interplay between CD22 and Galectin-9 and its influence on B-cell receptor signaling. Moreover, therapeutical approaches targeting human CD22 will be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brewer, C. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00364-0 · Cited by 435
Clowse, M. E. B., Wallace, D. J., Furie, R. A., Petri, M. A., Pike, M. C., Leszczyński, P., Neuwelt, C. M., Hobbs, K., Keiserman, M., Duca, L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39856 · Cited by 235 · cited 1×
“Epratuzumab has been used in clinical trials with systemic lupus erythematosus (SLE) patients but finally failed in the phase III study (99).”
MethodGalectin–glycan lattices regulate cell-surface glycoprotein organization and signalling
Garner, O. B., & Baum, L. G. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361472 · Cited by 226
Carnahan, J., Stein, R., Qu, Z., Hess, K., Cesano, A., Hansen, H. J., & Goldenberg, D. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.05.007 · Cited by 175 · cited 1×
“In contrast to the anti-CD20 antibody rituximab, it induces no complement-dependent cytotoxicity (CDC) and only moderate antibody-dependent cellular cytotoxicity (ADCC) (96).”
BackgroundCD22 ligation inhibits downstream B cell receptor signaling and Ca2+ flux upon activation
Sieger, N., Fleischer, S. J., Mei, H. E., Reiter, K., Shock, A., Burmester, G. R., Daridon, C., & Dörner, T. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37818 · Cited by 61 · cited 1×
“However, it rather modulates BCR signaling like calcium mobilization and phosphorylation of downstream signaling molecules (97, 98).”
Background
Cited by
Siglecs as Immune Cell Checkpoints in Disease
Duan, S., & Paulson, J. C. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102419-035900 · Cited by 452
“Other abbreviations: DC, dendritic cell; MHC, major histocompatibility complex. endogenously regulate TLRs (Figure 2b).”
BackgroundInfluentialKing, H. W., Orban, N., Riches, J. C., Clear, A. J., Warnes, G., Teichmann, S. A., & James, L. K. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe6291 · Cited by 263
Leung, K. K., Wilson, G. M., Kirkemo, L. L., Riley, N. M., Coon, J. J., & Wells, J. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917947117 · Cited by 83
The intriguing roles of Siglec family members in the tumor microenvironment
Jiang, K.-Y., Qi, L.-L., Kang, F.-B., & Wang, L. (2022) · Biomarker Research · doi:10.1186/s40364-022-00369-1 · Cited by 43
“As CD22 expression is restricted to B cells, it can serve as an important immunotherapeutic target in B-cell-related lymphomas [24, 31].”
BackgroundZiglari, T., Calistri, N. L., Finan, J. M., Derrick, D. S., Nakayasu, E. S., Burnet, M. C., Kyle, J. E., Hoare, M., Heiser, L. M., & Pucci, F. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-0875 · Cited by 11
Metadata
- Authors
- Meyer, S. J., Linder, A. T., Brandl, C., & Nitschke, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-12-03
- Volume
- 9
- Pages
- 2820-2820
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2903237949
- Cited by
- 83
- References
- 5
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: B Cell Siglecs–News on Signaling and Its Interplay With Ligand Binding. https://app.cochat.ai/papers/10.3389/fimmu.2018.02820
- The paper
- Meyer, S. J., Linder, A. T., Brandl, C., & Nitschke, L. (2018). B Cell Siglecs–News on Signaling and Its Interplay With Ligand Binding. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.02820
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.